H3827

Resolutions urging the Congress of the United States to update the Drug Addiction Treatment Act of 2000 and remove excessive training requirements mandated for obtaining a waiver to prescribe buprenorphine

Introduced·2/27/25
Introduced Text

Massachusetts H3827 urges Congress to update the Drug Addiction Treatment Act of 2000 and remove excessive training requirements for prescribing.

Massachusetts H3827 calls for the U.S. Congress to revise the Drug Addiction Treatment Act of 2000, specifically to eliminate stringent training requirements for physicians seeking to prescribe buprenorphine, a medication used to treat opioid addiction. The bill highlights the growing opioid crisis in the United States, noting the increasing number of opioid-related deaths and the need for effective treatment methods.

Included in complete analysis

  • Overview
  • Core Provisions
  • Implementation
  • Impact
  • Legal Framework
  • Critical Issues

See what it does, who it affects, and the critical issues in plain language. Free, 30 seconds.

Where it stands

Current
In committee
Next
Committee decision

Sponsors

D
1
0
Democratic CaucusRepublican Caucus

Calendar

Nov 13, 2025

1:00 PM

Joint Committee on Veterans and Federal Affairs Hearing

Nov 13, 2025

1:00 PM

Joint Committee on Veterans and Federal Affairs Hearing

History

Mar 23

House

Committee reported that the matter be placed in the Orders of the Day for the next sitting, the question being on adoption

Feb 19

House

Resolutions reported favorably by committee and referred to the committee on House Steering, Policy and Scheduling

Nov 13, 2025

Joint

Hearing rescheduled to 11/13/2025 from 01:00 PM-03:50 PM in B-1 and Virtual Hearing updated to New End Time